Fundraising FoxIter Investments — Full Portfolio
26 tracked investments · listed companies and verified rows first
Apex Labs is a biotechnology and emerging therapeutics company developing clinical solutions, likely focused on psychedelic-assisted therapies and drug development.
BiotechDigital HealthMedical DevicesMental Health
Tyler Powell(Chief Executive Officer, co-Founder & Director)inArron Victory(Chief Strategy Officer, co-Founder & Director)inDr. Peter Tomlinson(Chief Technical Officer, co-Founder & Director)inDr. Orion Lekos(SVP Research & co-Founder)
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao
Co-investorsBailey Venture PartnersFJ LabsLeafy TunnelMaiora Rebel VenturesNoeticPalo Santo VC+4 more
Beckley Retreats operates research-informed, legal psilocybin retreat programs, combining pre-retreat preparation, guided psilocybin sessions, and post-retreat integration for individuals seeking personal growth and greater connection.
Mental HealthTravel & HospitalityWellness & FitnessFrederick, US
Neil Markey(Executive Officer, Director)inAZA Allsop(Head of Research)inRock Feilding-Mellen(Director)
Fluence provides training and professional development in psychedelic therapy and integration for clinicians and researchers.
Digital HealthEdTechHealthtechMental Health
Co-investorsJLS
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.
BiotechDigital HealthMental Health
Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in
Co-investorsBeni Venture CapitalEvolution VC PartnersGaingelsLongeVCManta Ray VenturesPsyMed Ventures+3 more
__Twitter.png)
Muse is a brain-sensing wearable platform that combines EEG and fNIRS technology to help users improve sleep, manage stress, and enhance cognitive performance through real-time neurofeedback.
AI & Machine LearningConsumerHardwareHealthtechWellness & FitnessToronto, CA
Ariel Garten(Co-founder and Chief Evangelism Officer)inChris Aimone(Co-founder and Chief Innovation Officer)inTrevor Coleman(Executive Officer, Director)inDerek Luke(Executive Officer)Jean-Michel Fournier(Chief Executive Officer)in
BoardJason Wong(Director)
Co-investorsFf Venture CapitalInnovative Solutions CanadaNew Ground VenturesOMERS Ventures
Nucleus is a venture studio that launches, acquires, and partners with brands and technologies focused on mental wellness and the psychedelic medicine industry.
Digital HealthMental HealthWellness & Fitness
Co-investorsDelta-v Capital
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US
Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)inScott Rairigh(EVP, Corporate Development)inMagali Haas(Chief Medical Officer)in
Co-investorsBonaventure Equity, LLCMystic Ventures
Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use.
BiotechDeep TechHealthtechMedical DevicesMental Health
Danny Motyka(Co-Founder & CEO)inPeter van der Heyden(Co-Founder & Director)in
Co-investorsNoeticEight Capital
PsyTechGlobal provides educational content and business insights on the psychedelics industry, including research tracking and market analysis.
Media & EntertainmentWellness & FitnessPortland, US
Quantified Citizen operates a platform that enables health research studies to be conducted by making the research creation process accessible and globally distributed.
Digital HealthHealthtechMental HealthSaaS
Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.
BiotechDigital HealthHealthtechMental HealthNew York, US
John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)
Co-investorsGaingelsPsyMed Ventures
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersMission BiocapitalPalo Santo VCRoute 66 VenturesService Provider Capital+3 more
TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.
AgTechMental HealthWellness & FitnessVenice, US
Nanea Reeves(Founder)inZachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)
BoardTim Chang(Director)
Co-investorsBeni Venture CapitalBitkraft Esports VenturesGrit Capital PartnersHartmann CapitalMayfield FundPresence Capital+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
aNUmaAwakn Life SciencesClairvoyantClairvoyantrxFluenceFreedom BioMAPSMuseNucleus HoldingPsyTechWesana
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.